{"transactions":[{"id":1760958,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":109030,"kind":"person","name":"Andraczke Andrzej","position":1,"cik":"0001792732","reported_name":"Andraczke Andrzej","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-10-12T22:00:06.000Z","date":"2023-09-21","kind":"grant","planned":false,"acquired":true,"shares":39475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":45428,"derivative":{"exercise_price":1.09,"expiration_date":"2033-09-22","underlying":"Common Stock","underlying_shares":39475},"source":{"system":"sec-edgar","filing":"0001683168-23-007106","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316823007106/ownership.xml","form_type":"4/A","original_submission_date":"2023-09-25"}},{"id":1773746,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":109030,"kind":"person","name":"Andraczke Andrzej","position":1,"cik":"0001792732","reported_name":"Andraczke Andrzej","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-09-25T22:20:12.000Z","date":"2023-09-21","kind":"grant","planned":false,"acquired":true,"shares":68961,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":74914,"derivative":{"exercise_price":1.09,"expiration_date":"2033-09-22","underlying":"Common Stock","underlying_shares":68961},"source":{"system":"sec-edgar","filing":"0001683168-23-006676","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316823006676/ownership.xml","form_type":"4"}},{"id":2631565,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":109030,"kind":"person","name":"Andraczke Andrzej","position":1,"cik":"0001792732","reported_name":"Andraczke Andrzej","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2021-07-16T21:00:40.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":32000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the date hereof or the date of the 2022 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":178559,"derivative":{"exercise_price":1.8,"expiration_date":"2031-07-15","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001683168-21-002999","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316821002999/ownership.xml","form_type":"4"}},{"id":3108294,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":109030,"kind":"person","name":"Andraczke Andrzej","position":1,"cik":"0001792732","reported_name":"Andraczke Andrzej","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-06-16T21:22:54.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":46559,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":146559,"derivative":{"exercise_price":2.47,"expiration_date":"2030-06-12","underlying":"Common Stock","underlying_shares":46559},"source":{"system":"sec-edgar","filing":"0001683168-20-001965","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316820001965/ownership.xml","form_type":"4"}}]}